HCV Peptide (35-44) structure
|
Common Name | HCV Peptide (35-44) | ||
---|---|---|---|---|
CAS Number | 160214-01-7 | Molecular Weight | 1240.50000 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C57H97N19O12 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HCV Peptide (35-44)HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1]. |
Name | Hepatitis C virus core protein(35-44) |
---|---|
Synonym | More Synonyms |
Description | HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1]. |
---|---|
Related Catalog | |
In Vitro | HCV Peptide (35-44) (0-100 μM) 抑制总 NK 细胞群的脱颗粒。 HCV 肽 (35-44) 增加 HLA-C 和 HLA-E 的细胞表面表达[1]。 |
References |
Molecular Formula | C57H97N19O12 |
---|---|
Molecular Weight | 1240.50000 |
Exact Mass | 1239.76000 |
PSA | 513.57000 |
LogP | 4.16690 |
C35-44 |
peptide C 35-44 |
YLLPRRGPRL |
peptide C35-44 |